AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 15 filers reported holding AMBRX BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,101 | -95.9% | 5,574 | -94.2% | 0.00% | -100.0% |
| Q2 2023 | $1,570,284 | -31.1% | 95,400 | -62.7% | 0.00% | 0.0% |
| Q1 2023 | $2,280,558 | +32903.7% | 255,668 | +8299.1% | 0.00% | – |
| Q4 2022 | $6,910 | -23.2% | 3,044 | -61.8% | 0.00% | – |
| Q3 2022 | $9,000 | +800.0% | 7,967 | +3192.1% | 0.00% | – |
| Q2 2022 | $1,000 | – | 242 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 16,688,636 | $191,919,314 | 67.54% |
| Cormorant Asset Management, LP | 9,923,689 | $114,122,424 | 6.66% |
| COMMODORE CAPITAL LP | 3,518,556 | $40,463,394 | 4.73% |
| Ally Bridge Group (NY) LLC | 281,089 | $3,232,524 | 3.79% |
| Paradigm Biocapital Advisors LP | 3,488,596 | $40,118,854 | 2.72% |
| VR Adviser, LLC | 2,070,000 | $23,805,000 | 2.51% |
| Ghost Tree Capital, LLC | 525,000 | $6,037,500 | 1.99% |
| HighVista Strategies LLC | 193,701 | $2,227,562 | 1.03% |
| Ikarian Capital, LLC | 4,932 | $5,671,800 | 0.68% |
| APIS CAPITAL ADVISORS, LLC | 34,000 | $391,000 | 0.51% |